key: cord-0874471-bbn8juk1 authors: Mehrabian, Daniel; Liu, Ivan Z.; Pakhchanian, Haig H.; Tarawneh, Omar H.; Raiker, Rahul; Boyd, Carter J. title: Nationwide Analysis of Plastic and Reconstructive Procedural Volume in the United States During the COVID-19 Pandemic() date: 2021-12-03 journal: J Plast Reconstr Aesthet Surg DOI: 10.1016/j.bjps.2021.11.100 sha: a3850a4ce797eb49d844c6855a63d9b071c72583 doc_id: 874471 cord_uid: bbn8juk1 INTRODUCTION: This study aims to define the impact that the novel Coronavirus Disease 2019 (COVID-19) pandemic has had on the volume of common plastic and reconstructive procedures. METHODS: TrinetX is a national, federated database that was utilitzed in surveying plastic and reconstructive procedural volumes among 53 Healthcare organizations (HCO) between March 2018 and May 2021. This timeframe was divided into pre-pandemic (March 2018 to February 2020) and pandemic periods (March 2020 to May 2021). Each period was then sub-divided into the four seasons of the year and mean monthly procedural volume per HCO was compared. A student's t-tests comparing pre-pandemic and pandemic seasonal mean procedural volumes were used for statistical analysis. RESULTS: A total of 366,032 patient encounters among 53 HCO were included. The average seasonal volume per HCO of all procedures decreased from 872.11 procedures during pre-pandemic seasons to 827.36 during pandemic seasons. Spring 2020 volumes declined for most procedures as 15 of 24 (63%) assessed procedure categories experienced statistically significant decreases. Spring 2021 experienced rebounds with 15 of 24 (63%) assessed procedures showing statistically significant increases. CONCLUSION: During the pandemic period, the average procedural volume per HCO of 14 procedure categories was significantly less than the pre-pandemic average procedural volume. As a whole, there was a inverse relationship between new United States COVID-19 cases and plastic and reconstructive surgery procedure volumes. By the first quarter of 2020, the novel Coronavirus Disease 2019 (COVID-19) pandemic substantially affected the functional capacity of healthcare organizations (HCO) across the globe. Given the increased risk of spread through close contact and aerosolized transmission, surgical services were heavily impacted 1 . According to the American Hospital Association, estimates of the financial losses from March 2020 -June 2020 exceeded $202 billion, $161 billion of which was secondary to canceled surgical procedures 2 . The American College of Surgeons (ACS) published initial recommendations for the cessation of all elective procedures in March 2020 3 . Soon after, state, federal, and specialty-specific guidelines emerged [4] [5] [6] [7] . Specific plastic and reconstructive professional organization guidance was published by the American Society of Plastic Surgeons (ASPS). Outlined in their March 2020 correspondence, ASPS initially cautioned members to only provide care deemed "urgent or emergent" based on personal discretion 8 . Preliminary analysis during this time revealed plastic and reconstructive surgery to be among the three surgical services that saw the largest decrease in total operating room (OR) volume from March to June 2020 compared to the same period in 2019 9 . As of December 2020, current ASPS recommendations advise members to consult with hospital, local, county, state, and regional regulatory bodies regarding elective surgeries 10 . These regulations, however, have been highly variable across time and by region since the onset of the COVID-19 pandemic. Plastic and reconstructive surgery, with many elective and non-emergent procedures 11 , is particularly vulnerable to COVID-19 related barriers. Furthermore, the significant role of elective admissions and procedures in maintaining health system revenue viability 12,13 poses significant financial loss for all health system groups independent of size. Preliminary feedback from American Council of Academic Plastic Surgeons (ACAPS) self-reporting member surgeons corroborates the predicted initial limitation of plastic and reconstructive operational volume 14 . The longer-term impact of the COVID-19 pandemic on specific plastic and reconstructive procedures, however, has yet to be quantified in the literature. Therefore, the purpose of this study is to compare the common plastic and reconstructive procedural volumes in the United States during the pandemic to the two prior years. TrinetX (Cambridge, MA) is a national, federated database that was utilitzed in this retrospective study. Electronic medical records reported between March 2018 and May 2021 were analyzed. This platform consists of aggregate, de-identified electronic health records (EHR) reported by 53 continually updating HCOs and including more than 72 million patient records, with most HCO provided data dating back to 2014 15 . Given the exclusion of protected personal health information in the database ensure that the data is Health Insurance Portability and Accountability Act (HIPAA) compliant. Previous literature in plastic surgery has reported on data obtained from TrinetX. 16 A literature review was conducted to identify a representative sample of the most common plastic and reconstructive procedures nationally [17] [18] [19] [20] . TrinetX was queried for the associated Current Procedural Terminology (CPT) codes (Table 1) of both inpatient and outpatient operations. Monthly case volume as well as the corresponding number of reporting HCOs was compiled during the study period. To account for procedure specific changes in the number of reporting HCO, monthly mean operative volume per HCO was calculated on a CPT-specific level as well as in aggregate. The monthly CPT-specific volumes per HCO were clustered chronologically to calculate average volumes for three-month seasons throughout the study period. To provide a more meaningful baseline of pre-pandemic volume, a combination of the 2018 and corresponding 2019 figures were used. The following seasons were analyzed: Spring 2020 (March-May 2020), summer 2020 (June-August 2020), fall 2020 (September-November 2020), winter 2020/2021 (December 2020-February 2021), spring 2021 (March-May 2021) as well as their pre-pandemic analogs. Finally, an aggregate of the total pandemic period (March 2020 -May 2021) was compared to the corresponding figures in pre-pandemic timeframes. Descriptive analyses were performed, and comparisons were made using a student's t-test. Statistical analysis was performed using Microsoft Excel with a predetermined level of significance set at p<0.05 (Microsoft Inc., Washington, USA). A total of 366,032 plastic and reconstructive procedures from 53 HCO during March 2018 -May 2021 were included in this investigation. The procedure with the highest volume over the entirety of the March 2018 -May 2021 period analyzed was neuroplasty and/or transposition; median nerve at carpal tunnel with an aggregate operative volume of 51,395. Neuroplasty and/or transposition-median nerve at carpal tunnel also had the highest seasonal mean volume per HCO for four of the five pandemic seasons analyzed. Spring 2020 was the only season where the seasonal mean of neuroplasty and/or transposition-median nerve at carpal tunnel was not the highest average seasonal procedure volume per HCO. Over the entirety of the five pandemic periods analyzed, almost every procedure's seasonal mean volume differed from pre-pandemic figures. Spring 2020 exhibited the most decreases in procedural volume compared to any other season with 15 (50%) statistically significant reductions. Meanwhile, the largest count of statistically significant increases in procedure volume (15/30) was in Spring 2021. The seasonal mean volume over the aggregate March 2020 -May 2021 period of 10 procedures differed from aggregate March 2018 -February 2020 figures by a statistically significant amount (Table 5) . The first season included in our analysis, spring 2020, revealed a decrease in most mean procedural volumes per HCO relative to the 2018/2019 counterparts ( Table 2 ). On a procedure specific level, 15 of 24 (63%) experienced a statistically significant reduction in volume. Of these, excision, benign lesion including margins, except skin tag (unless listed elsewhere), trunk, arms or legs; excised diameter 1.1 to 2.0 cm (51%, p < 0.00039), excision, excessive skin and subcutaneous tissue (includes lipectomy); abdomen, infraumbilical panniculectomy (52%, p < 0.0014), reduction mammoplasty (46%, p < 0.0013), and revision of reconstructed breast (48%, p < 0.0042) were experienced the largest significant decreases. Repair, complex, forehead, cheeks, chin, mouth, neck, axillae, genitalia, hands and/or feet; 1.1 cm to 2.5 cm-7.5 cm had the highest aggregate operative volume per HCO across this season with an estimated 68 operations per HCO from March -May 2020. No statistically significant increases in mean procedural volume per HCO were observed during March -May 2020. The majority of procedures (21/30) saw a decline in volume for summer 2020, however, none of these decreases were statically significant (Table 3 ). On a procedure specific level, none of the fall 2020 volumes changed by a statistically significant amount compared to pre-pandemic figures (Table 3 ). There were seven decreases in volume, none of which were statistically significant (Table 3) . Fall 2020 volume changes from pre-pandemic figures were broadly similar to those of winter 2020/2021. On a procedure specific level, five changes were statistically significant (Table 3 ). There were two significant decreases: repair, complex, forehead, cheeks, chin, mouth, neck, axillae, genitalia, hands and/or feet-1.1 cm to 2.5 cm-7.5 cm (26%, p < 0.001); and mastopexy (17%, p < 0.037). Meanwhile, three procedures had a statistically significant increase in volumes: muscle, myocutaneous, or fasciocutaneous-upper extremity (34%, p < 0.050); full-thickness graft, free, including direct closure of donor site, forehead, cheeks, chin, mouth, neck, axillae, genitalia, hands, and/or feet-20 cm 2 or less (19%, p < 0.027); and free flap procedures (24%, p < 0.026). The final season included in our analysis, spring 2021, revealed 16 statistically significant changes with 15 of the 16 changes (94%) being statistically significant increases mean procedural volumes per HCO relative to the 2018/2019 counterparts ( Table 4 ). The largest of these increases in volume were: excision, sacral pressure ulcer (44%, p<0.030); full-thickness graft, free, including direct closure of donor site, forehead, cheeks, chin, mouth, neck, axillae, genitalia, hands, and/or feet; 20 cm 2 or less (41%, p<0.0032) and rhinoplasty, primary (46%, p<0.00030). Only one of the operations significantly declined in volume during this time frame: revision of reconstructed breast decreased by a statistically significant amount (17%, p < 0.023). This study presents a retrospective review of a large national cohort to analyze trends is operative case volume in plastic in reconstructive surgery during the COVID-19 pandemic. Seasonal analysis was performed to achieve an iterative evaluation of fluctuations in plastic and reconstructive surgery volume. To the best of the authors' knowledge, this is the first pandemic-related analyses of national operative volume in the subspecialty to date. The database utilized is continuously updated by numerous HCOs generates insights into obstacles to more patient-specific plastic and reconstructive care, providing more individualized implications for future healthcare delivery as we return to normality. This retrospective analysis demonstrates a significant decline in the gross volume of plastic and reconstructive procedures during the months immediately following the start of the COVID-19 pandemic. Comparison of spring 2020 mean procedural volumes per HCO to corresponding pre-pandemic figures suggests an accumulation of unmet need for plastic and reconstructive care during the pandemic. The creation of these 'backlogs' on a much smaller scale has been well documented in current literature analyzing elective procedures in several specialties 21-24 . Likewise, the similarity between spring 2018 and spring 2019 seasonal average procedural volumes per HCO lends credibility to the assumption of year over year stability of demand for plastic surgery procedures. As a result, the decline in mean procedural volumes per HCO in spring 2020 reflects an inability of plastic surgeons to provide surgical care for their patients due to both safety concerns and diverted healthcare resources in response to the COVID-19 pandemic. The mean seasonal procedure volume per HCO of repair, complex, forehead, cheeks, chin, mouth, neck, axillae, genitalia, hands and/or feet-1.1 cm to 2.5 cm-7.5 cm, for example, decreased by a statistically significant amount relative to corresponding pre-pandemic figures during four of the five seasons analyzed. Collectively, this suggests there may have been unmet need for plastic and reconstructive surgical care during the pandemic. Following the initial procedural decline in spring 2020, this analysis demonstrates gradual escalation in the number of cases performed across the country culminating in a compensatory increase in procedural volume compared to pre-pandemic levels witnessed in spring 2021 to address months of accrued backlogged cases. Ultimately, our findingings imply that as we experience future waves of new cases alongside novel variant strains of COVID-19 (i.e. delta and lambda variants), healthcare organizations will need to anticipate and prepare for seasonal variation in procedural volume. These chnages will likely follow procedure specific trends that track variaiton in new cases.This could change procedural and peri-and post-operative care protocols as well. As the pandemic continues, this could represent oppurtunities for utilization of telemedicine and other remote care options. Our utilization of the TriNetX dataset posed several limitations to our study. By nature of the deidentified EHR, patient information regarding case complexity, emergence, and severity was not available. Our data also could not be stratified geographically to assess mean procedural volume per HCO more accurately. Given the characteristically large HCOs reporting EHR data, TriNetX data may also contain unadjusted biases against smaller hospitals or individual practices. Finally, our data may have been limited by confounding variables. Stay at home mandates, for example, may have diminished traumatic injuries requiring plastic and reconstructive repair. Given the limited duration and inconsistency of mandate enforcement, this effect is likely limited to earlier in the course of the COVID-19 pandemic when mandates were more restrictive. Future investigations should focus on the economic and healthcare impacts of accumulated demand and backlog for plastic and reconstructive care. Increases in spring 2021 procedural volume could potentially be associated with deteriorations in surgical outcomes and patient quality and satisfaction measures. Investigation of these specific protocols reveal improvements in safety and efficiency necessary for delivery of plastic and reconstructive care in the era of COVID-19. These analyses may serve as guidelines for the plastic and reconstructive surgery community in the event of subsequent pandemics of this magnitude. Furthermore, by understanding backlogs created by reduced surgical volume, astute clinicians can adjust their practice to address the increased demand for various procedures. This investigation represents the first in study of its kind to define effects of COVID-19 on plastic and reconstructive operational volume on a national level. We found statistically significant decreases in common plastic and reconstructive surgeries in March to May 2020 compared to pre-pandemic levels and a subsequent significant increase in volume in March to May 2021 compared to pre-pandemic levels. The authors have no conflicts of interest. Surgery and COVID-19 Hospitals and Health Systems Face Unprecedented Financial Pressures Due to COVID-19 COVID-19: Guidance for Triage of Non-Emergent Surgical Procedures AMA praises government on elective surgery guidelines during pandemic Medicare Telemedicine Health Care Provider Fact Sheet The American Board of Surgery. COVID-19 Guidelines and Resources American Society of Plastic Surgeons. COVID-19 Statements Cutting through the COVID-19 surgical backlog American Society of Plastic Surgeons. Important Update to Considerations for the Continuation or Resumption of Elective Surgery and Visits What Is the Role of Plastic Surgery in Global Health? COVID-19 and the Financial Health of US Hospitals Truven Health Analytics), Elixhauser A (AHRQ), Andrews RM (AHRQ). Characteristics of Operating Room Procedures in U.S. Hospitals, 2011. HCUP Statistical Brief #170. February 2014. Agency for Healthcare Research and Quality The Impact of COVID-19-based Suspension of Surgeries on Plastic Surgery Practices: A Survey of ACAPS Members. Plastic and reconstructive surgery Comparing Surgical Site Occurrences in 1 versus 2-stage Breast Reconstruction via Federated EMR Network. Plastic and reconstructive surgery. Global open Trends in Medicare Reimbursement for Reconstructive Plastic Surgery Procedures: 2000 to 2019. Plastic and reconstructive surgery Open treatment of metacarpal fracture, single, includes internal fixation, when performed Neuroplasty, major peripheral nerve, arm or leg Open treatment of metacarpal fracture, single, includes internal fixation, when performed Neuroplasty, major peripheral nerve, arm or leg